comparemela.com

Latest Breaking News On - Antonio barra - Page 1 : comparemela.com

Monkeypox vaccines no longer need registration in Brazil

BRASILIA. KAZINFORM Brazil’s drug regulator Anvisa on Friday (Aug 19) unanimously decided to lift registration requirements for the import of drugs and vaccines aimed at preventing and treating monkeypox.

Brazil lifts registration requirements for monkeypox vaccines

Brazil lifts registration requirements for monkeypox vaccines
outbreaknewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outbreaknewstoday.com Daily Mail and Mail on Sunday newspapers.

Solution for the pandemic is the vaccination campaign, says Queiroga in Brazil s Senate CPI

RIO DE JANEIRO, BRAZIL - After the depositions of the first two Ministers of Health of Jair Bolsonaro s government, the Pandemic CPI on Thursday, May 6, heard the current holder of the portfolio, Marcelo Queiroga, and the President-Director of the Brazilian Health Regulatory Agency (ANVISA), Antonio Barra Torres. In his statement, Queiroga said that the solution to the pandemic is the vaccination campaign and stressed that the development of vaccines is a response from science to the crisis. In reference to the high numbers of cases and deaths from Covid-19 in the country at the time he took . . . To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here

Coronavirus: Russia-Brazil spat erupts over Sputnik vaccine snub

  BRASÍLIA, BRAZIL Brazil s health regulator said Thursday its decision to reject the Russian-made Sputnik V coronavirus vaccine was based on the developer s own data, after the latter threatened to sue for defamation. Brazilian regulators decision Monday to deny emergency use authorization for the vaccine has blown up into an all-out international row, with Sputnik V s makers accusing them of knowingly spreading false and inaccurate information without testing the vaccine themselves. The Brazilian agency, Anvisa, based the decision on evidence the vaccine carried a live version of adenovirus, a common cold-causing virus. It fired back defensively in a press conference that it had drawn that conclusion from information submitted by the Sputnik V vaccine developer itself.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.